<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Chemotherapy":14,
"Hypothyroidism":14,
"Malignancy":12,
"Review":9,
"Histiocytosis":2,
"Leukemia":4,
"radioiodine therapy":13,
"salivary gland dysfunction":2,
"sialadenitis":4,
"thyroid cancer":217,
"xerostomia":2,
"hyperinsulinemia":2,
"papillary thyroid cancer":61,
"functional outcomes":2,
"Cell block":2,
"fine needle aspiration cytology":6,
"immunohistochemistry":44,
"BRAFV600E mutation":6,
"Hashimoto's thyroiditis":2,
"anaplastic thyroid cancer":16,
"TP53":2,
"colon":2,
"oncogene":4,
"Apoptosis":15,
"Cell cycle":7,
"Medullary thyroid cancer":17,
"Endoscopic thyroidectomy":2,
"Minimally invasive surgery":3,
"Remote access":2,
"pediatric tumors":2,
"Core-needle biopsy":3,
"Fine-needle aspiration":27,
"Thyroid carcinoma":55,
"Thyroid nodule":62,
"Ultrasound":33,
"Ectopic thyroid":5,
"Surgery":20,
"Thyroid":133,
"PPARγ":2,
"End-stage renal disease":2,
"Kidney transplantation":2,
"Radioiodine":13,
"hepatocellular carcinoma":15,
"ovarian cancer":6,
"Cabozantinib":4,
"Medullary thyroid carcinoma":34,
"Papillary thyroid carcinoma":131,
"Snail":3,
"BRAF":29,
"Immunocytochemistry":3,
"Carcinomas":2,
"Lung adenocarcinoma":4,
"Survival":24,
"Cancer":62,
"Germline mutation":2,
"RET proto-oncogene":3,
"Mutation":11,
"RAS":10,
"RET/PTC":4,
"TGF-β1":2,
"MiRNA":11,
"Sarcoma":3,
"Sertoli-Leydig cell tumor":2,
"Cancer stem cell":6,
"Differentiation":3,
"Biopsy, fine-needle":4,
"Carcinoma, papillary":2,
"Thyroid gland":21,
"Ultrasonography":36,
"Meta-analysis":25,
"Nuclear power plants":2,
"Breast cancer":56,
"EMT":7,
"Metastasis":52,
"fine-needle aspiration biopsy":12,
"molecular diagnostic techniques":3,
"thyroid neoplasms":49,
"PAX8":3,
"Diagnosis":34,
"Elastography":12,
"cytology":26,
"fine needle aspiration":25,
"microcalcifications":2,
"parathyroid":5,
"proliferation":17,
"Polymorphism":4,
"late effects":2,
"pediatric oncology":2,
"radiation":13,
"small interfering RNA":2,
"Acute":2,
"Radiation-induced":2,
"Radioisotopes":2,
"FNA":7,
"calcitonin":11,
"TROP-2":2,
"124I PET/CT":3,
"Environment":2,
"Neoplasm":9,
"Systematic review":5,
"recurrence":26,
"bilaterality":2,
"lymph node metastasis":20,
"multifocality":6,
"Atypia of undetermined significance":6,
"obesity":7,
"BRAF mutation":11,
"central lymph node metastasis":3,
"extrathyroidal extension":6,
"Head and neck cancer":9,
"Head and neck surgery":3,
"Neck dissection":15,
"Robotic surgery":2,
"ALK":2,
"Lung cancer":14,
"Squamous cell carcinoma":7,
"Afirma":4,
"Genetic testing":2,
"Molecular markers":2,
"Thyroid nodules":30,
"Lymph node dissection":7,
"Lymph node metastases":6,
"Recurrent thyroid cancer":3,
"Radioactive iodine":10,
"TSH suppression":3,
"Adrenal":2,
"Multiple endocrine neoplasia":8,
"Pheochromocytoma":7,
"head and neck ultrasound":11,
"thyroid fine-needle aspiration":2,
"Papillary thyroid carcinoma (PTC)":3,
"tumor-associated macrophages":3,
"outcome":6,
"prognosis":58,
"risk stratification":2,
"Invasion":22,
"Parathyroid hormone":4,
"Parathyroidectomy":5,
"Primary hyperparathyroidism":3,
"Thyroid disease":4,
"colorectal cancer":10,
"tumorigenesis":5,
"Iodine radioisotopes":3,
"Molecular targeted therapy":3,
"Survival analysis":4,
"Thyroglobulin":25,
"Thyroid neoplasm":14,
"Medullary":5,
"Nrf2":2,
"biomarker":12,
"differentiated thyroid cancers":2,
"Melanoma":9,
"NRAS":2,
"thyroid hormone receptor":3,
"tumor growth":4,
"Diffusion-weighted imaging":2,
"atypia of undetermined significance (AUS)":3,
"Metabolic syndrome":2,
"Head and neck neoplasms":2,
"adrenocortical carcinoma":2,
"neuroblastoma":2,
"parathyroid tumors":2,
"thyroid tumors":4,
"DNA methylation":4,
"Epigenetics":5,
"Follicular Thyroid Carcinoma":8,
"Mediastinum":2,
"thyroid lesions":4,
"Neoplasms":9,
"Pregnancy":5,
"gene fusion":3,
"Differentiated thyroid cancer":22,
"Follicular thyroid cancer":3,
"Spine":3,
"Radionuclide imaging":3,
"131I":4,
"brain":3,
"single photon emission computed tomography-computed tomography":2,
"adolescents":3,
"childhood":2,
"incidence":14,
"population-based study":2,
"Papillary carcinoma":23,
"Papillary":12,
"antioxidants":2,
"malondialdehyde":2,
"Total thyroidectomy":12,
"goiter":7,
"goitre":2,
"differentiated thyroid carcinoma":30,
"thyroid hormone withdrawal":2,
"clear cell renal carcinoma":2,
"Extraskeletal myxoid chondrosarcoma":2,
"complication":4,
"risk factor":8,
"thyroid surgery":8,
"anaplastic thyroid carcinoma":13,
"diagnostic accuracy":2,
"cricoid reconstruction":2,
"laryngotracheal reconstruction":2,
"tracheal reconstruction":2,
"cervical":2,
"frozen sections":3,
"lymph node":8,
"Laryngeal cancer":5,
"Thyroid cartilage":2,
"breast carcinoma":3,
"Positron emission tomography":10,
"Carbon nanoparticles":3,
"triple negative breast cancer":3,
"Genetics":6,
"Akt":7,
"Synergism":2,
"Metastases":7,
"Pituitary":4,
"airway":2,
"cricoid":2,
"trachea":4,
"solid tumors":3,
"targeted therapy":8,
"TTF-1":7,
"radiation epidemiology":2,
"Angiogenesis":7,
"Chemokine receptor":2,
"Vascular endothelial growth factor":3,
"Epidermal growth factor receptor":3,
"Quantum dot":2,
"Triple-negative breast cancer":5,
"pediatric cancer":2,
"radiation therapy":6,
"PKM2":14,
"DTC":5,
"PET/CT":5,
"PET/MRI":2,
"follicular lesion of undetermined significance":4,
"gene expression classifier":5,
"indeterminate cytology":5,
"Central neck dissection":5,
"gastric cancer":9,
"CEA":2,
"Carcinoembryonic antigen":3,
"DWI":2,
"MRI":4,
"Magnetic resonance imaging":2,
"Thyroid transcription factor-1":2,
"CT":3,
"Substernal":2,
"Hypopharynx":2,
"Larynx":5,
"biological dosimetry":3,
"Rat":2,
"microcarcinoma":5,
"risk":7,
"thyroid-stimulating hormone":3,
"carcinoid":3,
"ovary":3,
"struma ovarii":6,
"teratoma":4,
"Environmental exposure":2,
"Bone density":2,
"Thyrotropin":5,
"thyroid transcription factor 1":2,
"follicular carcinoma":8,
"Bethesda system":3,
"galectin-3":3,
"papillary thyroid microcarcinoma":13,
"Bevacizumab":3,
"Liver metastasis":4,
"Liver resection":2,
"Neoadjuvant chemotherapy":4,
"Thyroid function":2,
"estrogen":2,
"tumor microenvironment":2,
"Radiotherapy":15,
"Differentially expressed genes":2,
"tumor suppressor":3,
"World Trade Center":2,
"cohort study":2,
"epidemiology":24,
"surveillance":6,
"BRAFV600E":4,
"drug resistance":5,
"Circulating epithelial cells":2,
"Prostate cancer":6,
"tumor targeting":2,
"CD133":3,
"Cancer stem cells":5,
"Signaling pathway":2,
"Head and neck squamous cell carcinoma":4,
"lenvatinib":8,
"sorafenib":12,
"Metastatic":3,
"Primary":2,
"incidental":2,
"incidentaloma":3,
"BRAF V600E":4,
"Medullary thyroid carcinoma (MTC)":2,
"lymphatic metastasis":7,
"MicroRNA-375":2,
"Curcumin":3,
"Matrix metalloproteinases":2,
"Iodine":5,
"Thyroïde":3,
"acoustic radiation force impulse":5,
"shear wave elastography":7,
"strain elastography":2,
"gene expression":9,
"Liver cancer":2,
"Autoimmunity":2,
"Hyperprolactinemia":2,
"Prolactin":5,
"Prolactinoma":5,
"Prolactinome":2,
"Thyroid diseases":2,
"non-small cell lung cancer":4,
"pathology":13,
"renal cell carcinoma":7,
"Acromegaly":2,
"Hyperparathyroidism":4,
"Fine-needle aspiration cytology":3,
"thyroid imaging reporting and data system":2,
"thyroid ultrasound":4,
"molecular genetics":3,
"Catalase":2,
"TTF1":2,
"p63":2,
"Carcinoma":9,
"Thyroidectomy":35,
"Oxyphilic":2,
"surgical treatment":3,
"hepatoma":2,
"pancreatic cancer":4,
"Hyperthyroidism":3,
"Thyrotoxicosis":3,
"radioactive iodine ablation":5,
"Lymphoma":4,
"Multidetector computed tomography":2,
"INFLAMMATION":3,
"malignant":2,
"nodule":5,
"Parathyroid adenoma":9,
"Thyroid volume":2,
"18F-FDG PET/CT":2,
"ACTH = adrenocorticotropic hormone":3,
"FSH = follicle-stimulating hormone":4,
"GH = growth hormone":4,
"LH = luteinizing hormone":4,
"TSH = thyroid-stimulating hormone":5,
"pituitary surgery":3,
"Biopsy":10,
"Thyroid ablation":2,
"rhTSH":2,
"18F-FDG-PET/CT":2,
"Thyroglossal cyst":2,
"Tiroidectomía":2,
"NF-κB":2,
"PTC":5,
"Twist1":3,
"Differential diagnosis":5,
"Therapy":10,
"Hypocalcemia":3,
"Parathyroid glands":3,
"TERT":7,
"molecular diagnostics":3,
"molecular pathology":3,
"pediatric":7,
"risk factors":7,
"lymph nodes":11,
"tumor progression":4,
"thyroid autoimmunity":2,
"Cell proliferation":7,
"Napsin A":4,
"radiation exposure":4,
"p53":3,
"Undifferentiated thyroid carcinoma":3,
"Langerhans cells":2,
"cutaneous metastasis":2,
"oncology":7,
"Comprehensive health care":2,
"Cáncer de tiroides":4,
"Bethesda":2,
"fine-needle aspiration (FNA)":6,
"follicular variant":5,
"Pancreatic ductal adenocarcinoma":2,
"Warburg effect":2,
"Children":5,
"Cáncer diferenciado de tiroides":2,
"STK11":2,
"Renal metastasis":2,
"socioeconomic status":2,
"Telomerase":3,
"Thyroid cancer, papillary":5,
"breast":5,
"BRAF V600E mutation":3,
"TERT promoter mutation":3,
"Tumor":5,
"conventional smear":3,
"liquid-based cytology":6,
"survivors":2,
"early detection of cancer":2,
"BAP1":2,
"Cancer genetics":2,
"Childhood cancer survivors":2,
"negative predictive value":2,
"procalcitonin":2,
"Cosmesis":2,
"Endocrine surgery":2,
"Follow-up":8,
"Outcomes":4,
"Ectopic":2,
"Thymoma":4,
"MicroRNA":13,
"Non-coding RNA":2,
"lncRNA":5,
"NF1":2,
"everolimus":3,
"next-generation sequencing":4,
"AKT pathway":2,
"Pembrolizumab":4,
"Type 2 diabetes":2,
"elasticity imaging techniques":2,
"reliability":2,
"reproducibility":2,
"shear-wave elastography":2,
"SEER":4,
"age":3,
"nomogram":3,
"WNT signaling":2,
"Gerotarget":3,
"elderly patients":2,
"adrenocortical neoplasm":2,
"aging":2,
"cysts":2,
"diabetes mellitus":3,
"endocrine tumors":2,
"Bone scintigraphy":2,
"I-131":3,
"irradiation":4,
"Adjuvant":2,
"Prospective":2,
"Quality of life":5,
"mortality":7,
"Comorbidity":3,
"Treatment":6,
"progression-free survival":3,
"radioiodine remnant ablation":2,
"surgical resection":2,
"Neck ultrasound":2,
"thyroid papillary carcinoma":5,
"lung":2,
"Cytomorphology":4,
"mucoepidermoid carcinoma":3,
"second primary malignancy":2,
"second primary tumor":2,
"recombinant human thyroid-stimulating hormone":2,
"thyroid isthmus":2,
"intensity-modulated radiotherapy":2,
"nasopharyngeal carcinoma":7,
"organs at risk":2,
"Elderly":4,
"rapid on-site evaluation":2,
"Hashimoto thyroiditis":3,
"ablation":4,
"magnetic resonance imaging (MRI)":2,
"prevalence":6,
"endoscopic":3,
"and End Results (SEER)":2,
"liquid-based preparation":2,
"methylation":4,
"robotic thyroidectomy":9,
"thyroiditis":3,
"Cancer incidence":6,
"Transaxillary approach":2,
"Voice":2,
"Korea":5,
"Core needle biopsy":4,
"Thyroid lymphoma":2,
"Thyroid malignancy":4,
"tumor size":2,
"follicular lesion of undetermined significance (FLUS)":2,
"malignancy risk":3,
"fine-needle aspiration biopsy (FNAB)":2,
"Long noncoding RNA":4,
"Diagnostic":2,
"FOXE1":3,
"Follicular thyroid lesion":2,
"Second cancer":3,
"overdiagnosis":2,
"PDAC":2,
"Exosomes":2,
"MicroRNAs":2,
"mucin":2,
"Clinical management":2,
"Tg":2,
"complications":3,
"safety":9,
"serum thyroglobulin":2,
"BMI = body mass index":2,
"classification":3,
"craniopharyngiomas":2,
"growth pattern":3,
"Antiangiogenic therapy":2,
"Targeted therapies":3,
"Familial adenomatous polyposis":3,
"β-Catenin":5,
"Autoimmune disease":2,
"Lobectomy":2,
"follicular":9,
"Tumor marker":2,
"hypoparathyroidism":6,
"sensitivity":5,
"specificity":4,
"ATA risk stratification":2,
"TNM staging":4,
"distant metastasis":4,
"nodal metastasis":2,
"MAPK":2,
"KRAS":4,
"NKX2-1":2,
"Salivary glands":2,
"adolescent":2,
"proteomics":2,
"cervical cancer":2,
"National Cancer Data Base":2,
"PTEN":3,
"follicular adenoma":4,
"RNA-seq":2,
"follicular variant of papillary thyroid cancer":2,
"incidence rate":2,
"esophageal cancer":2,
"BRAF(V600E)":3,
"neck":3,
"HCC":4,
"cell growth":2,
"sonography":6,
"Chemoresistance":6,
"TIRADS":2,
"SLUG":2,
"VEGF":4,
"growth":5,
"clinicopathological characteristics":2,
"relative survival":2,
"lifestyle":2,
"Kidney":2,
"Radiofrequency ablation":5,
"RET":11,
"tyrosine kinase inhibitors":7,
"Eyelid":2,
"brain metastasis":4,
"Chernobyl":2,
"Epithelial-mesenchymal transition":8,
"Leptin":2,
"Dual malignancy":2,
"TSH":4,
"Thyroid Hormone":2,
"Recombinant human thyrotropin":2,
"adenocarcinoma":5,
"migration":9,
"Tamoxifen":3,
"Adjuvant endocrine therapy":2,
"cetuximab":3,
"irinotecan":2,
"Adenoid cystic carcinoma":4,
"Strain ratio":2,
"image analysis":2,
"Heavy metals":2,
"Trace elements":2,
"Internet":2,
"Primary thyroid lymphoma":2,
"ROC curve":2,
"cytopathology":4,
"tissue microarray":2,
"resistance":3,
"Pituitary adenoma":4,
"disease-free survival":5,
"Hashimoto’s thyroiditis":5,
"interventional radiology":2,
"Papillary microcarcinoma":2,
"Radiofrequency":4,
"Virtual Touch tissue imaging":2,
"Programmed death-ligand 1":2,
"BRCA1":2,
"vandetanib":5,
"Hypoxia":3,
"screening":3,
"siRNA":2,
"Testicular cancer":2,
"exome sequencing":2,
"benign nodule":2,
"microenvironment":2,
"oncogenes":2,
"Frozen section":2,
"metabolism":5,
"papillary thyroid cancer (PTC)":4,
"radioiodine scan":2,
"Ultrasound-guided fine needle aspiration biopsy":2,
"ubiquitin-specific protease 22":2,
"Neuroendocrine tumor":5,
"Routine central lymph node dissection":2,
"Goserelin":2,
"spinal metastasis":3,
"hepatectomy":2,
"Dosimetry":6,
"epidermal growth factor receptor (EGFR)":2,
"head/neck":2,
"Flow cytometry":2,
"Lymphocytic thyroiditis":2,
"mimicking":2,
"PET-CT":2,
"Pitfalls":2,
"fine-needle":2,
"histology":2,
"Sunitinib":5,
"Central lymph node":2,
"Oxidative stress":4,
"IMRT":5,
"Palliative care":2,
"thyroid cytology":3,
"Parotid":2,
"Salivary gland":3,
"Neuroendocrine tumours":3,
"endoscopic surgery":3,
"poorly differentiated thyroid carcinoma":6,
"Prediction":2,
"Immunoassay":2,
"99mTc-MIBI":2,
"Follicular neoplasms":3,
"Scintigraphy":4,
"Cervical lymph node metastasis":2,
"Prophylactic lymph node dissection":2,
"Radioiodine ablation":3,
"Body mass index":2,
"laryngectomy":2,
"Radioactive iodine therapy":7,
"insular carcinoma":2,
"p40":2,
"Carcinogenesis":6,
"pharmacokinetics":4,
"population":3,
"Fine needle aspiration biopsy":2,
"miR-185":2,
"isoflavones":2,
"Pediatric thyroid cancer":3,
"Well differentiated thyroid carcinoma":2,
"Mutations":4,
"miRNAs":4,
"lateral neck dissection":3,
"gasless unilateral axillary approach":2,
"tyrosine kinase inhibitor":5,
"Phase I study":2,
"cell line":2,
"molecular biology":2,
"tall cell":2,
"Mass spectrometry":2,
"FNAC":3,
"histopathology":4,
"Cancers":2,
"Radioiodine refractory thyroid cancer":2,
"autophagy":6,
"metformin":2,
"thyroid stimulating hormone":2,
"ELISA":2,
"type 2 diabetes mellitus":2,
"computed tomography":7,
"infarction":2,
"leiomyosarcoma":2,
"hypercalcemia":2,
"parathyroid carcinoma":2,
"shRNA":2,
"Brain tumor":2,
"Glioblastoma":2,
"Paraganglioma":2,
"E-cadherin":3,
"Thyroid disorders":2,
"HBME-1":3,
"Endoscope":2,
"Surgical management":2,
"Metastatic thyroid cancer":2,
"KPS = Karnofsky Performance Scale":2,
"Lymph node excision":2,
"Overall survival":3,
"Familial medullary thyroid carcinoma":2,
"Laser":3,
"Neoplasm metastasis":4,
"124I":2,
"Efficacy":2,
"Neuroendocrine tumors":2,
"Genetic":2,
"management":4,
"machine learning":2,
"Macroadenoma":2,
"Survivor":2,
"Pain":3,
"FNAB":2,
"Oncogenesis":2,
"child":2,
"PI3K/Akt pathway":3,
"Skin":2,
"pancreas":4,
"macrophage":2,
"nanoparticle":2,
"Small cell lung cancer":2,
"predictive factors":2,
"ERK":2,
"thyroid transcription factor-1 (TTF-1)":2,
"Case report":4,
"fine-needle aspiration cytology (FNAC)":2,
"Variants":2,
"expression profile":2,
"Systemic therapy":2,
"Toxicity":3,
"Endoscopy":2,
"Conventional ultrasound":3,
"Primary squamous cell carcinoma":2,
"MEN2A":2,
"Contrast-enhanced ultrasound":2,
"Women":2,
"S-1":2,
"growth hormone":2,
"cancer risk":2,
"phenotype":2,
"case-control study":3,
"cartilage invasion":2,
"total laryngectomy":2,
"Follicular variant papillary carcinoma":2,
"NIFTP":3,
"Microwave":2,
"thermal ablation":2,
"Nodular Hyperplasia":3,
"Imaging":3,
"Nuclear":2,
"follicular neoplasm":4,
"Therapeutic target":2,
"Regorafenib":2,
"Carney complex":2,
"Medullary carcinoma":3,
"PKA":2,
"MAPK pathway":2,
"PI3K":3,
"RET mutations":2,
"Thailand":2,
"stroma":2,
"isthmus":2,
"molecular diagnosis":2,
"target therapy":2,
"BCPAP":2,
"Whole-body scintigraphy":2,
"Hürthle cell adenoma":2,
"FDG PET/CT":2,
"chemoradiation":2,
"SPECT/CT":2,
"Androgen receptor":2,
"Interleukin-6":2,
"Silencing mediator for retinoid and thyroid hormone receptors":2,
"MTC":2,
"Biopsia":2,
"Nódulo tiroideo":3,
"Hürthle cell":2,
"spinal metastases":2,
"fusion protein":2,
"Childhood acute lymphoblastic leukemia":2,
"Gonadotropin":2,
"TPC-1":2,
"Thymus neoplasms":2,
"CXCR4":3,
"Anaplastic carcinoma":2,
"Biomarkers":2,
"Cytokines":4,
"Ultrasonography, Doppler":2,
"active surveillance":3,
"Mammalian target of rapamycin":2,
"Pituicytoma":2,
"RET mutation":2,
"Bethesda System for Reporting Thyroid Cytopathology":2,
"bone metastases":2,
"Colon carcinoma":2,
"l-Thyroxine (T(4))":2,
"family history":2,
"indeterminate":2,
"nodules":4,
"Calcium":2,
"TNM":2,
"Myasthenia gravis":2,
"Familial thyroid cancer":3,
"calcification":2,
"Otolaryngology":2,
"follicular thyroid adenoma":2,
"oncocytic variant":2,
"FISH (fluorescence in situ hybridization)":2,
"HER2 (Human Epidermal Growth Factor Receptor 2)":2,
"IHC":2,
"CT, computed tomography":2,
"Benign":2,
"Single photon emission computed tomography":2,
"Hepatitis C Virus":2,
"thyroglobulin antibody":2,
"poorly differentiated":2,
"Spine surgery":2,
"humans":2,
"thyroid follicular carcinoma":2,
"therapeutics":2,
"Polymorphisms":2,
"pleural":2,
"metastatic thyroid carcinoma":2            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
